Incyte

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Incyte and other ETFs, options, and stocks.

About INCY

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development and commercialization of proprietary therapeutics. Its portfolio includes compounds in various stages, ranging from preclinical to late stage development, and commercialized products such as JAKAFI (ruxolitinib), and ICLUSIG (ponatinib). 

CEO
Herve Hoppenot
CEOHerve Hoppenot
Employees
2,094
Employees2,094
Headquarters
Wilmington, Delaware
HeadquartersWilmington, Delaware
Founded
1991
Founded1991
Employees
2,094
Employees2,094

INCY Key Statistics

Market cap
14.82B
Market cap14.82B
Price-Earnings ratio
15.67
Price-Earnings ratio15.67
Dividend yield
Dividend yield
Average volume
1.36M
Average volume1.36M
High today
$67.91
High today$67.91
Low today
$66.56
Low today$66.56
Open price
$66.84
Open price$66.84
Volume
1.61M
Volume1.61M
52 Week high
$84.86
52 Week high$84.86
52 Week low
$61.91
52 Week low$61.91

INCY News

Simply Wall St 4d
Incyte Corporation's Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Incyte (NASDAQ:INCY) has had a rough three months with its share price down 12%. However, stock prices are usually driven by a company’s financial performance o...

Incyte Corporation's Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Analyst ratings

52%

of 21 ratings
Buy
52.4%
Hold
42.9%
Sell
4.8%

INCY Earnings

$0.00
$0.39
$0.79
$1.18
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 1, Pre-Market
ActualExpected Nov 1, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.